BLAIRSVILLE, GA--(Marketwired - July 24, 2014) - United Community Banks, Inc. (NASDAQ: UCBI)
United Community Banks, Inc. (NASDAQ: UCBI) ("United") today reported net income of $16.4 million, or 27 cents per diluted share, for the second quarter of 2014.
Revenue from continuing operations for the second quarter of 2014 was $47.7 million, an increase of 28% compared to the second quarter of 2013; Operating income from continuing operations for the second quarter of 2014 was $7.6 million, an increase of 297% compared to the second quarter of 2013.
By Therese Poletti, MarketWatch
Amazon.com Inc. (AMZN) reported a greater-than-expected loss in the second quarter, partly due to an increase in capital spending, but a deceleration in revenue at its cloud-services business was also causing some concerns among investors.
ROCKVILLE, Md., July 24, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX) , a clinical stage biopharmaceutical company focused on discovering and identifying innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today announced that its investigational new drug (IND) for MGD007 has been cleared by the U.S. Food and Drug Administration (FDA) to proceed with the Phase 1 human clinical trial for this drug candidate.
Luxfer Group (NYSE:LXFR), a global materials technology company,
announced today that it will release financial results for the second
quarter ended June 30, 2014, after the market closes on Wednesday, July
The Board of Directors of Nielsen N.V. (NYSE:NLSN), a leading global
provider of information and insights into what consumers watch and buy,
today declared a quarterly cash dividend of 25 cents per share of common
DOWNINGTOWN, Pa., July 24, 2014 (GLOBE NEWSWIRE) -- DNB Financial Corporation (Nasdaq:DNBF) , parent of DNB First, National Association, the oldest nationally-chartered community bank serving the greater Philadelphia region, today reported financial results for the three and six months ended June 30, 2014.
PEABODY, Mass., July 24, 2014 (GLOBE NEWSWIRE) -- Meridian Interstate Bancorp, Inc. (the "Company") (Nasdaq:EBSB) , the holding company for East Boston Savings Bank, announced today the results of the stock offering of Meridian Bancorp, Inc., a newly formed corporation ("New Meridian") that is the proposed successor holding company for East Boston Savings Bank.
HOLLAND, Mich., July 24, 2014 (GLOBE NEWSWIRE) -- Macatawa Bank Corporation (Nasdaq:MCBC) today announced its results for the second quarter of 2014, continuing its trend of improvement in key operating metrics and financial performance.
Symetra Financial Corporation (NYSE: SYA) today reported second quarter
2014 adjusted operating income of $55.3 million, or $0.48 per diluted
share, compared with $52.7 million, or $0.40 per diluted share, for the
second quarter of 2013.
Qlik (NASDAQ: QLIK), a leader in data discovery delivering intuitive
solutions for self-service data visualization and guided analytics,
today announced financial results for the second quarter ended June 30,
Operating Income per Share Is $1.70; Combined Ratio Is 90.0% including Catastrophe Impact of 4.8 Points 2014 Operating Income per Share Guidance Is Revised to Range of $6.75 to $6.95
WARREN, N.J. , July 24, 2014 /PRNewswire/ -- The Chubb Corporation (NYSE: CB) today reported that net income in the second quarter of 2014 was $499 million compared to $579 million in the second quarter of 2013.
Orange Capital, LLC (“Orange Capital” or “we”), today issued the
following statement in regards to its investment in the shares of
Pinnacle Entertainment, Inc. (“Pinnacle” or the “Company”) (NYSE:PNK):
On April 16, 2014 Orange Capital sent a letter
No. 1 Prescribed Allergy Treatment Ingredient(1) to be Available OTC PARSIPPANY, N.J. , July 24, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No.
DUBLIN , July 24, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration (FDA) for its previously approved New Drug Application (NDA) for testosterone gel 1.0%. FDA concluded that Perrigo's testosterone product is therapeutically equivalent to [AbbVie's] AndroGel 1% and can be substituted with the full expectation that it will produce the same clinical effect and safety profile as AndroGel 1% when used under the conditions specified in the labeling.
Sign-up for - QR ENERGY SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of QR Energy, LP (QRE) Board of Directors in Connection With the Proposed Sale of the Company to Breitburn Energy Partners (BBEP) investment picks
NEW YORK, July 24, 2014 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced that trading of Intersect ENT (Nasdaq:XENT) , a commercial drug-device company, commenced on The NASDAQ Stock Market on July 24, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.